Key Insights

Highlights

Success Rate

77% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

9.4%

3 terminated out of 32 trials

Success Rate

76.9%

-9.6% vs benchmark

Late-Stage Pipeline

9%

3 trials in Phase 3/4

Results Transparency

20%

2 of 10 completed with results

Key Signals

2 with results77% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (11)
P 1 (3)
P 2 (6)
P 3 (2)
P 4 (1)

Trial Status

Completed10
Recruiting10
Not Yet Recruiting4
Terminated3
Unknown3
Active Not Recruiting1

Trial Success Rate

76.9%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (32)

Showing 20 of 20 trials
NCT07539311Phase 2RecruitingPrimary

Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers

NCT07554807Phase 3Not Yet Recruiting

A Randomized, Double-blind, Placebo-controlled, Prospective, Multi-center Trial Evaluating the Improvement of Nutritional Status and Sarcopenia With Silkworm Pupa Tablets in Patients With Malignancies

NCT07529808Phase 1Not Yet Recruiting

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

NCT05984589Not ApplicableRecruiting

Personalized Health Self-Management Training for Colorectal Cancer Survivors

NCT06681233Not ApplicableRecruiting

Feasibility Study of CBCT for IGRT in Cancer Patients

NCT06955468Not ApplicableCompleted

Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology

NCT07184047CompletedPrimary

Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers

NCT07406269Not ApplicableNot Yet Recruiting

Clinical Evaluation of AI Decision Support for Early Rehabilitation After Surgery

NCT05641896Phase 2CompletedPrimary

Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers

NCT07272538CompletedPrimary

Predicting Chemotherapy Toxicity Using FRAIL and FIND in Older Adults With Gastrointestinal Cancers

NCT07098871RecruitingPrimary

Predictive Value of Preoperative Rectus and Diaphragm Muscle Thickness for Postoperative Complications in Gastrointestinal Cancer Surgery

NCT07039526Phase 2Recruiting

Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.

NCT06731998Not ApplicableRecruiting

Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery

NCT07180251Not ApplicableActive Not Recruiting

Impact of Glycemic Variability on People With Gastrointestinal Cancer and Diabetes After Surgery

NCT07173244Not Yet Recruiting

A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors

NCT06908629Not ApplicableRecruiting

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

NCT06872489Unknown

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

NCT07017712Completed

Sex Differences in Gastrointestinal Cancer Surgery

NCT06077487Phase 4Terminated

Ketamine-assisted Therapy for Advanced GI Cancer

NCT06966232Phase 3RecruitingPrimary

Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers

Scroll to load more

Research Network

Activity Timeline